Reckitt Benckiser pays $1.4 billion in opioid settlement

LONDON — Consumer products company Reckitt Benckiser says it will pay $1.4 billion to resolve U.S. investigations into the marketing of an anti-addiction drug by a subsidiary.

The company said Thursday it reached agreements with the U.S. Department of Justice and the Federal Trade Commission.

The government alleged that an ex-Reckitt subsidiary sought to increase prescriptions for Suboxone Film by deceiving health care providers into believing the drug was safer than other opioid addiction treatments.

Suboxone Film was marketed by RB's former prescription business Indivior, which was spun off in 2014.

The company says it "acted lawfully at all times and expressly denies all allegations that it engaged in any wrongful conduct" but the settlement was in the best interest of RB and shareholders.

It said the settlement would prevent uncertainty and distraction from continued investigations.

Must Read

George Michael mourned by boyfriend, ex-boyfriend...

Dec 27, 2016

George Michael's former partner and his current boyfriend have both spoken of their sadness at his...

A Kink, former Spice Girl and Vogue editor to get...

Dec 31, 2016

Queen Elizabeth II's New Year honors list focuses on sports stars, some luminaries of fashion and...

Duchess of Cambridge meets families at children's...

Jan 24, 2017

The Duchess of Cambridge has paid an emotional visit to a children's hospice in a village northeast...

'A truly magnificent talent:' actor John Hurt...

Jan 28, 2017

As a self-described "old drunk," the actor John Hurt nonetheless had a half-century career...

Prince William calls for end to stigma on mental...

Feb 7, 2017

Prince William is speaking out about ending the stigma surrounding mental health treatment

Sign up now!